4.4 Article

Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar

Related references

Note: Only part of the references are listed.
Letter Infectious Diseases

Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam

Mallika Imwong et al.

LANCET INFECTIOUS DISEASES (2017)

Review Microbiology

The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread

Charles J. Woodrow et al.

FEMS MICROBIOLOGY REVIEWS (2017)

Editorial Material Pharmacology & Pharmacy

Can new treatment developments combat resistance in malaria?

Nicholas J. White

EXPERT OPINION ON PHARMACOTHERAPY (2016)

Review Biotechnology & Applied Microbiology

Malaria medicines: a glass half full?

Timothy N. C. Wells et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Article Microbiology

High-Throughput Ultrasensitive Molecular Techniques for Quantifying Low-Density Malaria Parasitemias

Mallika Imwong et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2014)

Article Medicine, General & Internal

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

E. A. Ashley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Spiroindolone KAE609 for Falciparum and Vivax Malaria

Nicholas J. White et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Microbiology

Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia

Benoit Witkowski et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Infectious Diseases

Artemisinin-induced parasite dormancy: a plausible mechanism for treatment failure

Andrea Codd et al.

MALARIA JOURNAL (2011)

Article Microbiology

Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, Uganda

Julia Mwesigwa et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Article Public, Environmental & Occupational Health

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria

Elizabeth A. Ashley et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)

Review Infectious Diseases

Artemisinin-based combinations

EA Ashley et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2005)

Article Public, Environmental & Occupational Health

Ex-vivo short-term culture and developmental assessment of Plasmodium vivax

K Chotivanich et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)

Article Microbiology

Mefloquine pharmacokinetic-pharmacodynamic models: Implications for dosing and resistance

JA Simpson et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)

Article Microbiology

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

F Ezzet et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)

Article Public, Environmental & Occupational Health

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria

M van Vugt et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)